(NDSN) Nordson Corporation Bundle
What does Nordson Corporation do?
Nordson Corporation is a Nasdaq-listed precision technology company that engineers equipment, components and systems for dispensing, applying, controlling, testing, inspecting and processing materials. Its products are used in factories rather than consumer storefronts: adhesive dispensing for packaging, coating equipment for industrial production, fluid components for medical devices, polymer processing systems, precision agriculture spray controls, electronics dispensing systems, and test-and-inspection equipment for semiconductor and printed circuit board production.
What problem does precision technology solve?
Nordson matters because many manufacturing processes depend on applying a tiny quantity of adhesive, coating, sealant, biomaterial, solder paste, lubricant or agricultural input in the right place, at the right speed and with repeatable quality. The company’s fiscal 2025 Form 10-K describes a business built around differentiated products, application expertise, direct global sales and service, and a customer base spread across packaging, electronics, medical, appliances, energy, transportation, precision agriculture, construction and general assembly.
The plain-English story is that Nordson sells critical manufacturing tools, not commodity equipment. A packaging producer wants adhesive systems that reduce glue waste and avoid downtime. A medical-device company wants tubing, balloons, cannulas and fluid components made to tight requirements. A semiconductor assembly line wants controlled dispense, plasma treatment and inspection. These are small pieces of the customer’s capital stack, but they can influence yield, uptime and product quality.
How does Nordson make money, and which segments matter most?
Nordson primarily makes money by selling specialized equipment, systems, parts and consumables to industrial, medical and technology customers. Revenue is generally product-driven: the annual report says revenue usually comes from short-term, fixed-price contracts and is primarily recognized when products ship or control transfers, while less than 10% of FY2025 revenue was recognized over time. The model is attractive when Nordson’s installed base, application expertise and aftermarket support create repeat orders, replacement parts, upgrades and customer retention.
What is the revenue logic?
| Revenue engine | How it earns | Customer need | Research implication |
|---|---|---|---|
| Equipment and systems | Sales of standard and customized production tools | Precision, uptime, quality, line speed | Cyclical because customers time capital spending, especially in electronics and industrial markets. |
| Components and consumables | Fluid components, tips, syringes, medical parts and related products | Repeatable performance in regulated or high-quality processes | Can add durability because customers often qualify components into production processes. |
| Aftermarket and service | Support, spares, training and application expertise | Lower downtime and process optimization | Strengthens switching costs and protects margins even when new-equipment demand softens. |
Which segment generates the most revenue?
Industrial Precision Solutions is the largest segment, but Nordson is not a one-segment story. In FY2025, IPS generated $1.33B, or 47.7% of sales; Medical and Fluid Solutions generated $835.4M, or 29.9%; and Advanced Technology Solutions generated $624.5M, or 22.4%. The mix matters because each segment has a different cycle: IPS leans toward packaging, industrial, agriculture and polymer processing; MFS has medical and engineered-fluid exposure; ATS is more tied to electronics, semiconductor production and inspection.
| Segment | FY2025 sales | FY2025 segment EBITDA | EBITDA margin | Business interpretation |
|---|---|---|---|---|
| Industrial Precision Solutions | $1.33B | $493.9M | 37.1% | Largest contributor; tied to dispensing, coating, polymer processing and agriculture cycles. |
| Medical and Fluid Solutions | $835.4M | $311.7M | 37.3% | Smaller than IPS but similarly high margin; product qualification and medical applications matter. |
| Advanced Technology Solutions | $624.5M | $146.6M | 23.5% | More electronics-exposed; margin recovery is a key signal when semiconductor demand improves. |
What does the latest quarter show?
The freshest official reporting package is the fiscal second quarter ended April 30, 2026. Nordson’s Q2 FY2026 earnings release reported second-quarter record sales of $740.8M, up 8.5% year over year. The release and the Form 10-Q for the quarter ended April 30, 2026 show organic growth in all three segments, a favorable currency contribution, and management’s decision to raise full-year sales and adjusted EPS guidance.
What changed in Q2 FY2026?
The quarter’s key message is broad demand recovery. IPS sales rose 9.9%, MFS sales rose 5.0%, and ATS sales rose 10.1%. Organic sales growth was 5.0% for IPS, 7.8% for MFS and 8.5% for ATS. This is important because Nordson’s 2024 and 2025 narrative included pockets of electronics and industrial weakness; Q2 FY2026 suggests electronics dispense, engineered fluid solutions, medical product lines, industrial coating, polymer processing and precision agriculture were moving in the same positive direction.
| Q2 FY2026 metric | Value | Comparison or context | Why it matters |
|---|---|---|---|
| Sales | $740.8M | Up 8.5% year over year | Shows broad demand improvement across all segments. |
| Gross profit | $404.1M | 54.5% gross margin | Supports the view that differentiation protects pricing and mix. |
| Total EBITDA | $235.2M | 32% of sales | Management’s preferred non-GAAP profitability lens remained strong. |
| Net income | $117.3M | Up 4.4% year over year | Growth was reduced by a $24.0M pension settlement charge and minority-investment losses. |
| Backlog | Up 18% | Compared with the prior year | Backlog and order entry supported higher FY2026 guidance. |
How did segment momentum look?
How financially strong is Nordson through the cycle?
Nordson’s financial profile is better read through margins and cash conversion than through revenue growth alone. FY2025 sales grew 3.8% to $2.79B, but organic sales declined 2.5% as acquisitions and divestitures changed the portfolio. Yet the company still produced $711.7M of operating profit, $484.5M of net income, $719.2M of operating cash flow and $661.1M of free cash flow. That combination explains why investors often treat Nordson as a high-quality industrial compounder rather than a simple machinery cyclical.
What does cash flow say?
For the first six months of FY2026, operating cash flow was $321.1M and capital expenditures were $27.7M, implying roughly $293.4M of free cash flow before dividends. During that same six-month period Nordson repaid $107.1M of long-term debt, repurchased $129.3M of common shares and paid $91.6M of dividends. The company is using cash for a balanced mix of debt reduction, shareholder returns and reinvestment rather than depending on one lever.
What does the balance sheet allow?
| Financial item | Apr. 30, 2026 | Oct. 31, 2025 | Interpretation |
|---|---|---|---|
| Cash and equivalents | $102.0M | $108.4M | Cash is not the main liquidity source; borrowing capacity and operating cash flow are more important. |
| Total current assets | $1.28B | $1.24B | Receivables and inventory move with the production cycle. |
| Long-term debt | $1.84B | $1.68B | Leverage is material after acquisition spending, but covenant compliance and credit capacity remain central. |
| Shareholders’ equity | $3.20B | $3.04B | Retained earnings and accumulated returns support a long-cycle capital allocation model. |
| Available borrowings and unused lines | $1.05B | Not comparable in release | Liquidity supports acquisitions, working capital, dividends and buybacks. |
Which strategic turning points explain Nordson today?
Nordson’s history is relevant because today’s business is the result of repeated moves from one precision niche into adjacent niches. The official company history traces the roots to U.S. Automatic Company in 1909, the 1954 creation of Nordson around “hot airless” coating patents, international expansion, adhesive dispensing, electronics, medical, polymer processing, test and inspection, and the 2021 launch of the Ascend strategy. The pattern is consistent: use engineering depth and customer process knowledge to enter specialized manufacturing applications.
Which historical decisions still matter?
-
1954Nordson begins around hot-airless coating patents; the company’s origin is proprietary industrial application technology rather than general machinery.
-
1960sHot-melt adhesive equipment and powder coating expand the model from paint finishing into higher-volume bonding and coating processes.
-
1970sSales exceed $100M and shares begin trading on Nasdaq, giving the company public capital-market access.
-
1996-2000Acquisitions add UV curing, gas plasma and precision electronics dispensing, forming the core of the later Advanced Technology Solutions platform.
-
2007Dage and Yestech move Nordson deeper into electronic test and inspection, widening the moat from dispensing into process verification.
-
2010sMedical acquisitions including biomaterial dispensing, medical fluid flow control, catheters and tubing build a more healthcare-oriented profit pool.
-
2021-2026The Ascend strategy, Atrion, CyberOptics, NDC Technologies and CapstanAG show a portfolio still shifting toward high-value medical, electronics, measurement and precision agriculture niches.
What gives Nordson a competitive advantage?
Nordson’s moat is not just patents, even though the FY2025 filing cites more than 2,100 granted and pending patents and more than 1,000 trademarks. The company itself says its advantage is also attributable to technical, marketing and sales competence. That distinction matters. Patents can expire, but customer process knowledge, direct sales coverage, installed equipment, service relationships and application expertise are harder to replicate quickly.
Where does the moat come from?
The strongest evidence is margin stability. Nordson posted gross margins of 55.2% in both FY2025 and FY2024, even though FY2025 organic sales were negative and the company was digesting portfolio changes. Segment EBITDA margins were 37.1% in IPS, 37.3% in MFS and 23.5% in ATS for FY2025. Q2 FY2026 again showed consolidated EBITDA at 32% of sales. For an industrial company, these are evidence of differentiated products, not merely volume scale.
Who are Nordson's main competitors?
Nordson’s official filings do not frame competition as one simple head-to-head rivalry. Instead, the company says it competes in a global marketplace against large, well-established manufacturers and service providers, plus alternative bonding, sealing, finishing, coating, processing, testing, inspecting and fluid-control techniques. For research purposes, the right peer set changes by segment: fluid handling and dispensing peers for IPS and MFS, test-and-inspection peers for ATS, and diversified industrial technology companies for valuation context.
Which peer groups matter most?
Who owns Nordson stock, and what does governance signal?
Nordson is not a dual-class founder-control story. Its investor profile is closer to a dispersed public company with large passive institutions, a meaningful Nord-family-descendant trust-related holder, and relatively low director-and-officer beneficial ownership as a group. The 2026 proxy statement reported 55.7M common shares outstanding as of Jan. 2, 2026, and disclosed that directors, director nominees and executive officers as a 17-person group beneficially owned 470,304 shares, less than 1%.
What does ownership say about control?
| Holder or group | Shares beneficially owned | Percent of shares | Source period | Why it matters |
|---|---|---|---|---|
| The Vanguard Group | 6,069,686 | 10.9% | Jan. 2, 2026 proxy table | Large passive ownership means governance votes and capital allocation discipline matter. |
| BlackRock, Inc. | 3,855,103 | 6.9% | Jan. 2, 2026 proxy table | Another major passive institution; not a strategic controller. |
| State Street Corporation | 2,957,894 | 5.3% | Jan. 2, 2026 proxy table | Reinforces the institutional shareholder base. |
| Jennifer A. Savage | 2,945,523 | 5.3% | Jan. 2, 2026 proxy table | Includes trusts for Nord family descendants, preserving a historical family-linked ownership signal. |
| Directors and executive officers as a group | 470,304 | Less than 1% | Jan. 2, 2026 proxy table | Management influence comes more from board mandate and incentives than voting control. |
The proxy also clarifies incentives. Annual cash incentives use total revenue and total operating profit, while performance share units are weighted 40% to adjusted EPS growth, 30% to ROIC and 30% to EBITDA margin. For students and investors, that matters because management is explicitly rewarded for growth plus returns, not just revenue scale. It aligns with the Ascend strategy’s emphasis on profitable growth, acquisition discipline and margin quality.
What opportunities and risks could change Nordson's outlook?
Nordson’s opportunity set is tied to three growth vectors: recovery in electronics and semiconductor-related production, continued medical and fluid component expansion, and precision agriculture or industrial applications that reward lower waste and higher automation. Q2 FY2026 was encouraging because organic growth appeared in all segments and backlog rose 18% year over year. Management raised FY2026 guidance to $2.93B-$3.01B of sales and adjusted EPS of $11.30-$11.80, with Q3 FY2026 sales expected at $760M-$790M.
Which risks are most material?
The risk side is equally company-specific. Nordson sells into customer capital budgets, so demand can pause when electronics, industrial production or agriculture customers delay investments. The annual report also highlights tariffs, trade policy, export controls, foreign currency, geopolitical instability, acquisition integration, data privacy, cybersecurity, product quality, environmental compliance and international operations. These are not abstract warnings: 66.9% of FY2025 sales were generated outside the United States, so currency and trade policy can move reported results.
| Risk or opportunity | Evidence or metric | Financial line affected | What to monitor |
|---|---|---|---|
| Electronics recovery | ATS Q2 FY2026 sales up 10.1% | Segment sales and EBITDA margin | Electronics dispense orders and ATS margin improvement. |
| Medical start-up headwinds | MFS Q2 FY2026 EBITDA margin slipped 50 bps | Segment EBITDA | Whether new product ramps convert into margin expansion. |
| Trade policy and tariffs | Global manufacturing and 66.9% non-U.S. FY2025 sales | Sales, cost of sales, gross margin | Tariff changes, export controls and supply-chain location decisions. |
| Acquisition discipline | Goodwill of $3.33B at Apr. 30, 2026 | ROIC, amortization, impairment risk | Integration, organic growth and return on acquired capital. |
| Cash deployment | $129.3M buybacks and $91.6M dividends in first six months FY2026 | Share count, leverage, dividend coverage | Balance between buybacks, dividends, debt paydown and bolt-on M&A. |
Which KPIs should researchers monitor?
Why does Nordson matter for DCF valuation and research?
For a DCF model, Nordson is interesting because the headline revenue growth rate understates the quality of the economics. The company combines modest long-run sales growth, high gross margins, strong EBITDA margins, relatively limited capital expenditures and recurring service or component demand. The key valuation question is not simply “how fast can sales grow?” but “how long can Nordson sustain premium margins and cash conversion while reinvesting into medical, electronics, precision agriculture and industrial niches?”
How should a DCF model frame the business?
| DCF driver | Current evidence | Upside case | Pressure case |
|---|---|---|---|
| Revenue growth | FY2025 sales up 3.8%; Q2 FY2026 sales up 8.5% | Broad organic growth and backlog conversion | Industrial or electronics capex pause |
| Gross margin | 55.2% in FY2025; 54.5% in Q2 FY2026 | Pricing, mix and service keep margin stable | Tariffs, mix pressure or lower factory absorption |
| Operating margin | 25.5% in FY2025; 26.6% in Q2 FY2026 | Operating leverage in ATS and MFS | Start-up costs, integration costs or weaker mix |
| Reinvestment rate | FY2025 capex was $58.1M versus $719.2M operating cash flow | High cash conversion funds buybacks and bolt-on deals | Acquisitions require more debt or lower returns |
| Terminal risk | Diversified end markets and direct global service | Precision applications keep expanding | Technology shifts reduce demand for specific processes |
The practical modeling lesson is that Nordson’s terminal value is sensitive to margin durability and reinvestment quality. A low-capex, high-margin industrial company can justify a stronger cash-flow profile than a commodity manufacturer, but the model must still haircut cyclical demand, acquisition risk, foreign currency exposure and the possibility that electronics or industrial customers delay orders.
What is the key takeaway from Nordson analysis?
Nordson is best understood as a precision-process company that has spent decades expanding from coating and adhesive dispensing into medical components, electronics dispense, test and inspection, polymer processing and precision agriculture. Its importance comes from the fact that small, specialized systems can protect customer yield, quality and uptime. That creates a business with higher margins and stronger cash conversion than many readers expect from an industrial equipment company.
The supporting evidence is current and concrete: FY2025 sales were $2.79B, gross margin was 55.2%, operating profit was $711.7M, free cash flow was $661.1M, and Q2 FY2026 sales rose 8.5% to $740.8M with backlog up 18%. The weak points are also clear: Nordson remains exposed to capital spending cycles, electronics volatility, trade policy, currency, acquisition integration and the need to keep specialized technology relevant as manufacturing processes change.
Readers who need the primary filings should start with Nordson’s official SEC filings page and the company’s business overview, because those sources provide the cleanest bridge between the operating story and the reported financial statements.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
